VAERS reports by lot

Moderna COVID-19 lot 026120A: VAERS reports

65 VAERS reports list lot 026120A as a Moderna COVID-19 vaccine, received between 2021-01-05 and 2023-10-03. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
65
Reports
0%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)7126%
Injection-site / Local reaction4818%
Neurological3413%
Dermatological (non-injection-site)2610%
Gastrointestinal259%
Musculoskeletal187%
Cardiac / Cardiovascular176%
Allergic / Anaphylactic145%
Respiratory114%
Thrombotic / Hematological21%
Psychiatric / Neuropsychiatric21%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

Illinois17
Georgia7
Indiana4
Pennsylvania4
New Jersey4
New York4
Ohio3
Michigan2
Mississippi2
Massachusetts2
Rhode Island1
Florida1

Reports by month received

2021-0133
2021-029
2021-033
2021-041
2021-051
2021-089
2021-112
2022-013
2022-021
2023-051
2023-091
2023-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.